Completed NCT00034229
This summary needs review. Please check the official study record and contact the research team for details.
In United States Why is this study shown? This study includes Bipolarity among several conditions.
Bipolarity, Depression Drug i A study involving a medication or substance.
Countries United States
Sponsor National Institute of Mental Health (NIMH)
Condition Bipolarity, Depression Completed NCT00025792
This summary needs review. Please check the official study record and contact the research team for details.
In United States Why is this study shown? This study includes Bipolarity among several conditions.
Bipolarity, Depression Drug
Countries United States
Sponsor National Institute of Mental Health (NIMH)
Condition Bipolarity, Depression Completed NCT00001285
This summary needs review. Please check the official study record and contact the research team for details.
In United States Why is this study shown? This study includes Bipolarity among several conditions.
Depression, Bipolarity Other
Countries United States
Sponsor National Institute of Mental Health (NIMH)
Condition Depression, Bipolarity Completed NCT00001544
This summary needs review. Please check the official study record and contact the research team for details.
In United States Why is this study shown? This study includes Bipolarity among several conditions.
Schizophrenia, Bipolarity Other
Countries United States
Sponsor National Institute of Mental Health (NIMH)
Condition Schizophrenia, Bipolarity Terminated NCT01928446
This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand whether a digital app or remote support tool can work better when mental health difficulties overlap with substance use.
Remote / online Why is this study shown? This study includes Bipolarity among several conditions.
Suicidality, Depression, ... Drug
Countries United States
Sponsor VA Office of Research and Development
Condition Suicidality, Depression, ... Completed NCT00001146
This study is completed in the United States. It focuses on Bipolarity.
In United States Why is this study shown? This study includes Bipolarity among several conditions.
Bipolarity, Depression Drug
Countries United States
Sponsor National Institute of Mental Health (NIMH)
Condition Bipolarity, Depression Unknown NCT04846010
This summary needs review. Please check the official study record and contact the research team for details.
In United States Why is this study shown? This study includes Bipolarity among several conditions.
Depression, Anxiety, ... Drug
Countries United States
Sponsor All Natural Medicine Clinic, LLC
Condition Depression, Anxiety, ... Completed NCT00001170
This summary needs review. Please check the official study record and contact the research team for details.
In United States Why is this study shown? This study includes Bipolarity among several conditions.
Bipolarity, Depression Other
Countries United States
Sponsor National Institute of Mental Health (NIMH)
Condition Bipolarity, Depression Completed NCT00029640
This summary needs review. Please check the official study record and contact the research team for details.
In United States Why is this study shown? This study includes Bipolarity among several conditions.
Depression, Bipolarity Other
Countries United States
Sponsor National Institute of Mental Health (NIMH)
Condition Depression, Bipolarity Completed NCT03818256
This study is completed in the United States. It is testing safety, Efficacy, and Pharmacokinetics of Miricorilant for schizophrenia.
In United States Why is this study shown? This study includes Bipolarity among several conditions.
Bipolarity, Schizophrenia Drug From 18 Years to 65 Years
Countries United States
Sponsor Corcept Therapeutics
Condition Bipolarity, Schizophrenia Completed NCT01072929
This study is completed in the United States. It is testing armodafinil Treatment for depression.
In United States Why is this study shown? This study includes Bipolarity among several conditions.
Bipolarity, Depression Drug From 18 Years to 65 Years
Countries United States
Sponsor Cephalon
Condition Bipolarity, Depression Terminated NCT03643159
This study was terminated in the United States. It focuses on depression.
Remote / online Why is this study shown? This study includes Bipolarity among several conditions.
Depression, Bipolarity, ... Drug From 18 Years to 63 Years
Countries United States
Sponsor Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition Depression, Bipolarity, ...